Pharmacokinetics and bioequivalence of nateglinide in healthy volunteers
Tan Zhi-rong,Ou-yang Dong-sheng,Han Chun-ting,Zhou Gan,Chen Yao,Zeng Ling,Guo Dong,Zheng Jiao,Han Yang,Peng Liang,Wang Lian-sheng,Li Zhi,Wang Dan,Hu Dong-li,Zhou Hong-hao
2006-01-01
Abstract:OBJECTIVE To establish an HPLC method to determine the concentration of nateglinide in the human plasma and to study its pharmacokinetics,relative bioequivalence of nateglinide capsules and tablets in 18 healthy volunteers.METHODS A single oral dose of 90 mg nateglinide capsules or tablets was given to healthy volunteers in an open randomized two-way cross-over design.The separation was performed on a Diamonsil C_(18) column(250 mm×1.5 mm,5 μm).The mobile phase was composed of acetonitril-0.02 mol·L~(-1)(40∶60).And the column temperature was 40 ℃ with the flow rate was 1.0 mL·min~(-1).The detection wavelength was 214 nm.RESULTS The calibration curve of nateglinide was linear within 0.187 5～12 μg·mL~(-1)(r~2=0.995 47),and the validated limit of quantitation was 0.093 75 μg·mL~(-1).The average recovery was 103%±7%;the intra-day RSD and inter-day RSD were both lower than 6.8%.The pharmacokonetic parameters of nateglinide test preparation were as follows:t_(max) was(1.36±0.40)h,C_(max) was(6.42±0.30)μg·mL~(-1),t_(1/2β) was(1.36±2.26)h,and AUC_(0～∞h) was(16.10±1.54)μg·h·mL~(-1),which(accorded) with the two-compartment model.CONCLUSIONS This method is simple,accurate,reproducible,and suitable for the determination of concentration and pharmacokinetics of nateglinide.Statistical analysis showed that the reference preparation and the test preparation were bioequivalent.